Colorectal cancer
PRINCIPAL INVESTIGATORS
- Mercedes Martinez Villacampa
- Xavier Sole Acha
- Cristina Santos Vivas
- Gemma Soler Gonzalez
- Rebeca Sanz Pamplona
CLINICAL RESEARCHERS
- Antonio Soriano Izquierdo
- Francisco Rodriguez Moranta
- Ferran Losa Gaspa
- Albert Sueiras Gil
- Esther Kreisler Moreno
- Domenico Nicola Fraccalviri
- Jose Carlos Ruffinelli Rodriguez
- Nuria Mulet Margalef
POSTDOCTORAL RESEARCHERS (R2)
- Robert Carreras Torres
- Marisa Martinez Muñoz
- Mireia Obon Santacana
- David Cordero Romera
- Maria Henar Alonso Aguado
- Ville Nikolai Pimenoff
- Ana Isabel Romero Morales
PREDOCTORAL RESEARCHERS (R1)
- Joan Mas Lloret
- Virginia Diez Obrero
- Ania Alay Badosa
- Sandra Garcia Mulero
- Sara Hijazo Pechero
- Ainhoa Garcia Serrano
SCIENTIFIC SUPPORT
- Nuria Mila Diaz
- Elisabet Guino Domenech
- Luisa Carmen De La Peña Negro
- Daniel Azuara Garcia
- Susana Lopez Ruiz
- Anna Diez Villanueva
- Ferran Moratalla Navarro
- Pilar Medina Lopez
- Carmen Rosa Atencia Rojas
- Jordi Godes Bonet
- Isabel Padrol Martin
- Jesus Moreno Castro
- Adriana Lopez-Doriga Guerra
- Isela Giro Brinot
MANAGEMENT SUPPORT
- Adelaida Piera Sancerni
- Francesc Alarcon Moral
- Olga Lopez Ciercoles
- Helena Peña Paris
- Josipa Bilic Zimmermann
- Teresa Fuentes Catalan
- Claudia Lorena Latorre Gaviria
- Paula Ximena Fernandez Calotti
Cancer
Oncobell
Scientific production
76
PAPERS
33 PUBLICATIONS IN FIRST DECILE
*Average Journal IF
59 PUBLICATIONS IN FIRST QUARTILE
Selected publications:
- Vermorken J, Cervantes A, Morsing P, Johansson K, Andersson T, Roest NL, Gullbo J, Salazar R . A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer.. ANNALS OF ONCOLOGY. 10.1093/annonc/mdz155.132
- Santos C, Azuara D, Viéitez JM, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Aranda E, Salazar R . Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.. ANNALS OF ONCOLOGY. 10.1093/annonc/mdz082
- Serra O., Galán M., Ginesta M., Calvo M., Sala N., Salazar R.. Comparison and applicability of molecular classifications for gastric cancer. CANCER TREATMENT REVIEWS. 10.1016/j.ctrv.2019.05.005
- Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V, Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group. False-Positive Results in a Population-Based Colorectal Screening Program: Cumulative Risk from 2000 to 2017 with Biennial Screening.. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 10.1158/1055-9965.EPI-18-1368
- Pimenoff VN, Tous S, Benavente Y, Alemany L, Quint W, Bosch FX, Bravo IG, de Sanjosé S . Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.. INTERNATIONAL JOURNAL OF CANCER. 10.1002/ijc.31964
Research highlights
PROJECTS
8 Ongoing projects
3 Started projects
14 ongoing clinical trials
4 Started clinical trials
PUBLISHED WORKS
2 Clinical guidelines
Selected projects
- Genetic and metabolomics screening towards the precision medicine in cancer prevention (1/10/2018 – 30/9/2023) PI: MORENO AGUADO, VICTOR. Funder: ASOCIACION ESPAÑOLA CONTRA EL CANCER.
- Estudio de las interacciones microbioma-anfitrión para la prevención del cáncer colorrectal (Colonbiome) (1/1/2018 – 31/12/2020) PI: MORENO AGUADO, VICTOR. Funder: FIS-Instituto de Salud Carlos III.
- Mejora de la selección de pacientes candidatos a terapia anti-EGFR en cáncer colorrectal metastasico: eficacia según los nuevos subtipos moleculares (mesenquimal versus canónico) (1/1/2017 – 30/6/2021) PI: SALAZAR SOLER, RAMON. Funder: FIS-Instituto de Salud Carlos III.
- Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (1/1/2016 – 30/5/2020) PI: SALAZAR SOLER, RAMON. Funder: VHIO.
- Phase II, open-label, single arm, multicenter study of Encorafenib, Binimetinib Plus Cetuximab in subjects with previously untreated BRAFV600E -mutant metastatic colorectal cancer (24/1/2019 – ) PI: RUFFINELLI RODRÍGUEZ, JOSÉ CARLOS. Funder ref.: W00090 GE 2 01.
- A randomized, multicentre, open-label controlled phase II trial of Foxy-5 as neo-adjuvant therapy in subjects with WNT-5A low colon cancer (5/3/2019 – 5/3/2025) PI: SANTOS VIVAS, CRISTINA. Funder ref.: SMS-0472B.
- Estudio abierto, aleatorizado, fase 3 comparando Trifluridina/Tipiracilo (S95005) en combinación con Bevacizumab y Capecitabina en combinación con Bevacizumab en primera línea de tratamiento de pacientes con cáncer colorrectal metastásico que no son candidatos a terapia intensiva (Estudio Solstice) (11/6/2019 -) PI: SOLER GONZÁLEZ, GEMMA. Funder ref.: CL3-95005-006 (SOLSTICE).
- Efectividad y tolerabilidad de ustejinumab en la práctica clínica en pacientes con enfermedad de crohn activa (10/5/2019 – ) PI: RODRIGUEZ MORANTA, FRANCISCO. Funder ref.: JAN-CRD-2018-01 (CNTO1275CRD4028).